BTSG vs. HIMS, OPCH, GH, RDNT, SHC, SGRY, PRVA, CON, LFST, and WGS
Should you be buying BrightSpring Health Services stock or one of its competitors? The main competitors of BrightSpring Health Services include Hims & Hers Health (HIMS), Option Care Health (OPCH), Guardant Health (GH), RadNet (RDNT), Sotera Health (SHC), Surgery Partners (SGRY), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), LifeStance Health Group (LFST), and GeneDx (WGS). These companies are all part of the "healthcare" industry.
BrightSpring Health Services vs.
BrightSpring Health Services (NASDAQ:BTSG) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, profitability, earnings, dividends, media sentiment, valuation, community ranking, risk and analyst recommendations.
BrightSpring Health Services has a beta of 2.58, meaning that its share price is 158% more volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 2.09, meaning that its share price is 109% more volatile than the S&P 500.
63.5% of Hims & Hers Health shares are held by institutional investors. 3.4% of BrightSpring Health Services shares are held by insiders. Comparatively, 13.7% of Hims & Hers Health shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Hims & Hers Health has lower revenue, but higher earnings than BrightSpring Health Services. BrightSpring Health Services is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.
In the previous week, Hims & Hers Health had 29 more articles in the media than BrightSpring Health Services. MarketBeat recorded 38 mentions for Hims & Hers Health and 9 mentions for BrightSpring Health Services. Hims & Hers Health's average media sentiment score of 0.74 beat BrightSpring Health Services' score of 0.61 indicating that Hims & Hers Health is being referred to more favorably in the news media.
BrightSpring Health Services presently has a consensus price target of $23.56, indicating a potential upside of 5.92%. Hims & Hers Health has a consensus price target of $38.00, indicating a potential downside of 31.10%. Given BrightSpring Health Services' stronger consensus rating and higher probable upside, research analysts clearly believe BrightSpring Health Services is more favorable than Hims & Hers Health.
Hims & Hers Health received 18 more outperform votes than BrightSpring Health Services when rated by MarketBeat users. However, 87.50% of users gave BrightSpring Health Services an outperform vote while only 35.38% of users gave Hims & Hers Health an outperform vote.
Hims & Hers Health has a net margin of 8.19% compared to BrightSpring Health Services' net margin of -0.38%. Hims & Hers Health's return on equity of 10.97% beat BrightSpring Health Services' return on equity.
Summary
Hims & Hers Health beats BrightSpring Health Services on 12 of the 18 factors compared between the two stocks.
Get BrightSpring Health Services News Delivered to You Automatically
Sign up to receive the latest news and ratings for BTSG and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
BrightSpring Health Services Competitors List
Related Companies and Tools
This page (NASDAQ:BTSG) was last updated on 6/11/2025 by MarketBeat.com Staff